Pharmacy Disclosure Log 2023

  1. AML and CLL Response 7920
  2. AML and CLL Response 8462
  3. Antibiotic Administration Set Line Flushing Response 8129
  4. Anti-Diabetic Products for the Formulary Response 7953
  5. Asthma Treatment Response 8046
  6. Asthma Response 8290
  7. Asthma Response 8521
  8. Biologic and Biosimilar Products Response 7883
  9. Biologic and Biosimilar Products Response 8090
  10. Biologic Medicines in Dermatology Response 8093
  11. Biologic Medicines in Dermatology Response 7889
  12. Biologic Medicines in Gastroenterology Response 8136
  13. Biologic Medicines in Gastroenterology Response 8383
  14. Biologic Medicines in Dermatology Response 8333
  15. Biologic Drugs Response 8351
  16. Biologic and Biosimilar Products Response 8328
  17. Bladder Cancer Response 8486
  18. Blood Cultures Response 8407
  19. Blood Tests in Maternity Services Response 8202
  20. Breast Cancer Response 8165
  21. Breast Cancer Response 8404
  22. Cancer Treatments Response 8334
  23. Cancer Treatments Response 8334 - Attachment
  24. Cancer Treatment Response 8383
  25. Chitin Chitosan Response 8186
  26. Colorectal Cancer Response 8487
  27. Dabrafenib and Trametinib in cancer treatment Response 8031
  28. Dermatology and Respiratory Medicine Response 8054
  29. Dermatological Conditions Response 8055
  30. Digital Test Results Access for Patient Response 8345
  31. Durolane Response 8536
  32. Early Access to Medicines Scheme (EAMS) Response 8051
  33. Formularies and Committees Response 8120
  34. Electronic Prescribing System Response 8417
  35. Gastric Oesophageal cancer and Ovarian Cancer Response 8468
  36. Gastroenterology Response 7930
  37. HIV & PrEP Response 8183
  38. Histology Response 8104
  39. Histology Response Attachment 8104
  40. Homecare Medicine Services Response 8262
  41. Homecare Medicine Services Response 8262 - Attachment
  42. Immunoglobulin Treatments Response 8460
  43. Immunomodulatory Medications Response 8331
  44. Immunoglobulin Treatments Response 8017
  45. Immunoglobulin Treatments Response 8017
  46. Incidence and Treatment of Urothelial and Colorectal Cancer Response 8218
  47. Intraosseous Blood Samples Response 8098
  48. Intra-Vitreal Injections or Implants Response 8343
  49. Intra-Vitreal Treatments Response 8378
  50. Juvenile Arthritis with Systemic Onset Response 8511
  51. Local Formulary Response 7898
  52. Lung Cancer Response 8389
  53. Lung Cancer Response 8158
  54. Lung Cancer Request 8158 - Attachment
  55. Medications within Dermatology and Respiratory Medicine Response 8281
  56. Migraine Response 8147
  57. Multiple Myeloma Response 8184
  58. Myelofibrosis Response 8465
  59. Myelofibrosis Response 8194
  60. Myelofibrosis Response 8194 - Attachment
  61. NHS Healthcare Treatment Response 8131
  62. NHS Drug Expiry Costs Response 8016
  63. Nivolumab Response 8241
  64. Nivolumab Response 8533
  65. Non-Small Cell Lung Cancer Response 8217
  66. Oesophageal and Gastric Cancer Response 8210
  67. Non-Small Cell Lung Cancer Response 7952
  68. Oesophageal and Gastric Cancer Response 7991
  69. Ovarian Cancer Response 8106
  70. Patients Receiving Treatment Response 8212
  71. Pharmacy & Prescribing Function Response 8339
  72. Pharmacy & Prescribing Function Response 8339 Attachment
  73. Pharmacy Aseptic Services Response 8348
  74. Pharmacy Aseptic Services Response 8415
  75. Rare Diseases Response 8418
  76. Rare Diseases Response 8418 -Attachment
  77. Renal Cell Carcinoma Response 8161
  78. Renal Cell Carcinoma Response 8396
  79. Renal Cell Carcinoma Response 8396 - Attachment
  80. Renal Cell Carcinoma Response 8161 Attachment
  81. Renal Cell Carcinoma Response 7957
  82. Renal Cell Carcinoma Response 7957 - Attachment
  83. Ruxolitinib Response 8270
  84. Self-Administration of Medication Response 8105
  85. Spinal Muscular Atrophy Response 7886
  86. Spinal Muscular Atrophy Response 7886 - Attachment
  87. Targeted Medications within Dermatology Response 8509
  88. Treatment of Dermatological Conditions Response 8296
  89. Treatment of Inflammatory Diseases Response 8293
  90. Treatment of Inflammatory Diseases Response 8293 - Attachment
  91. Treatment of Inflammatory Diseases Response 8293
  92. Treatment of Inflammatory Diseases Response 8293 - Attachment
  93. Treatments Response 8455
  94. Treatment of Breast Cancer Response 7965
  95. Treatment for Myelofibrosis Response 7986
  96. Treatment of Myelofibrosis Response 7986 - Attachment
  97. Treatment of Melanoma Response 8032
  98. Treatment of Urothelial and Colorectal Cancer Response 7998
  99. Unlicensed Aseptically Prepared Medicines Response 8213
  100. Unlicensed Aseptically Prepared Medicines Response 8213 - Attachment
  101. Uterine Fibroids or Endometriosis Response 8315
  102. Uterine Fibroids or Endometriosis Response 8315 - Attachment